Natural food retailer Mrs. Green's Natural Market confirmed its acquisition of seven Superfresh grocery locations in Maryland and one Superfresh location in Washington, D.C., from the Great Atlantic and Pacific Tea Co.
Retail spending for the month of May experienced a slight drop of 0.2% to $387.1 billion, though the advanced estimates noted that May sales were 7.7% higher than the year-ago period, the U.S. Census Bureau said Tuesday.
GlaxoSmithKline has garnered strong interest in its portfolio of legacy brands that were placed on the sales block earlier this year, according to a Reuters report published Tuesday. And that interest is likely to pick up in the coming months, GSK CEO Andrew Witty told reporters during a meeting of pharmaceutical industry executives.
Moody's Investors Service compared the three largest pharmacy benefit managers — CVS Caremark, Express Scripts and Medco Health Solutions — in a report issued Tuesday. While it maintained a positive view of all three, it gave CVS Caremark the highest credit rating.
A company that develops insulin-pump technology without tubing, such as the OmniPod insulin management system, has acquired a durable medical equipment distributor that specializes in direct-to-consumer sales of diabetes supplies.
Fred's on Thursday reported sales of $143.5 million for the four weeks ended May 28, up 1%. Comparable-store sales for the month rose 0.2%, compared with an increase of 3.5% in the same period last year.
Schiff Nutrition on Tuesday announced its $40 million acquisition from Ganeden Biotech of the worldwide exclusive rights to use the probiotic technology GanedenBC30 in the over-the-counter and dietary supplement space, along with the brands Sustenex and Digestive Advantage, under which GanedenBC30 currently is sold.
Japanese cosmetics company Pola Orbis Holdings plans to acquire H2O Plus, a privately held developer, manufacturer and marketer of prestige, branded marine-based natural skin care products for the face and body.
Capital spending for the retail industry is expected to increase 16% in 2011 to $42.5 billion, with all subsegments projecting double-digit percentage increases — except for mass merchants, whose growth is projected to rise 9% — according to a survey by Equity Research.
Costco Wholesale EVP, CFO and director Richard Galanti told investors during the company’s third quarter 2011 earnings call last week that average prices in pharmacy probably would decline due to the introduction of generic versions of branded drugs.